Sculptor Capital LP Solid Biosciences Inc. Put Options Transaction History

Sculptor Capital LP

  • $2.76 Billion
  • Q2 2024

Put Options

2 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2021

Aug 16, 2021
SELL
$3.49 - $5.51 $52,699 - $83,201
-15,100 Closed
0 $0
Q4 2020

Feb 16, 2021
BUY
$3.08 - $7.79 $46,508 - $117,629
15,100 New
15,100 $114,000

Others Institutions Holding SLDB

# of Institutions
2
Shares Held
97
Call Options Held
0
Put Options Held
0
View Full List

About Solid Biosciences Inc.

SLDB Quotes by TradingView
  • Ticker SLDB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 7,533,080
  • Market Cap $53.2M
  • Description
  • Solid Biosciences Inc. engages in developing therapies for duchenne muscular dystrophy in the United States. The company's lead product candidate is SGT-001, a gene transfer candidate, which is in a Phase I/II clinical trial to drive functional dystrophin protein expression in patients' muscles; and SGT-003, a ext-generation gene transfer candid...
More about SLDB
Track This Portfolio

Track Sculptor Capital LP Portfolio

Follow Sculptor Capital LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sculptor Capital LP, based on Form 13F filings with the SEC.

News

Stay updated on Sculptor Capital LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email